Everlywell Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 500
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Latest Deal Amount
  • $75M
Latest Deal Amount
  • Investors
  • 28

Everlywell General Information

Description

Developer of testing kits intended to provide access to transparent and insightful lab tests. The company develops do-it-yourself kits for a wide range of at-home regulatory-compliant diagnostic tests including food sensitivity, fertility, hormones, STDs, thyroid, and metabolism among the others, enabling users to perform tests at home and receive physician-reviewed results and insights on mobile devices.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 823 Congress Avenue
  • Austin, TX 78701
  • United States
+1 (512) 000-0000

Everlywell Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Everlywell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 15-Jan-2021 $75M 00000 Completed Generating Revenue
7. Later Stage VC (Series D) 03-Dec-2020 00000 00000 00.00 Completed Generating Revenue
6. Later Stage VC (Series C) 21-Feb-2020 0000 000.00 Completed Generating Revenue
5. Early Stage VC (Series B) 16-Apr-2019 0000 000.00 00000 Completed Generating Revenue
4. Seed Round 28-Dec-2017 000.00 000.00 000.00 Completed Generating Revenue
3. Angel (individual) 16-Nov-2017 000 00.00 0000 Completed Generating Revenue
2. Seed Round 19-Apr-2016 $2.5M $2.5M 00.00 Completed Product In Beta Test
1. Accelerator/Incubator 01-Jan-2016 Completed Startup
To view Everlywell’s complete valuation and funding history, request access »

Everlywell Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A-1 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A 7,926,690 $0.000010 6% $1.29 $1.29 1x $1.29 22.01%
Seed 4,174,804 $0.000010 6% $0.75 $0.75 1x $0.75 11.59%
To view Everlywell’s complete cap table history, request access »

Everlywell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of testing kits intended to provide access to transparent and insightful lab tests. The company develops do-it
Diagnostic Equipment
Austin, TX
500 As of 2021
00000
00000000000 00000

000000 0

r sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000000000 000000000
San Francisco, CA
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00

00000000

at nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserun
0000000000 000000000
Dublin, Ireland
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Everlywell Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Modern Fertility Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
00000000000000 Venture Capital-Backed Dublin, Ireland 000 00000 00000000000 00000
0000 Venture Capital-Backed Chicago, IL 00 000.00 00000000000 000.00
000000 Venture Capital-Backed Redwood City, CA 00 00.000 00000000000 00.000
0000000000 Corporation Schwerin, Germany
You’re viewing 5 of 10 competitors. Get the full list »

Everlywell Executive Team (14)

Name Title Board Seat Contact Info
Julia Cheek Founder & Chief Executive Officer
Joshua Stanley Chief Operating Officer & Chief Financial Officer
Nick Parker Chief Technology Officer
Jenifer Dasho Chief Marketing Officer
Stace Houk Chief People Officer
You’re viewing 5 of 14 executive team members. Get the full list »

Everlywell Board Members (3)

Name Representing Role Since
Garheng Kong Ph.D Self Board Member 000 0000
Judith Rodin Ph.D Self Board Member 000 0000
Michael Smerklo Next Coast Ventures Board Member 000 0000
To view Everlywell’s complete board members history, request access »

Everlywell Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Everlywell Investors (28)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
HealthQuest Capital Venture Capital Minority 000 0000 000000 0
Anthony Pompliano Angel (individual) Minority 000 0000 000000 0
BlackRock Asset Manager Minority 000 0000 000000 0
Daniel Gnecco Angel (individual) Minority 000 0000 000000 0
Foresite Capital Management Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 28 investors. Get the full list »

Everlywell Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000 000000 24-Mar-2021 000000000000000000 Diagnostic Equipment
PWNHealth 24-Mar-2021 Merger/Acquisition Laboratory Services (Healthcare) 00000 00000
To view Everlywell’s complete acquisitions history, request access »

Everlywell Subsidiaries (2)

Company Name Industry Location Founded
PWNHealth Laboratory Services (Healthcare) New York, NY 2015
0000 000000 000000 Diagnostic Equipment Hoffman Estates, IL 0000
To view Everlywell’s complete subsidiaries history, request access »